◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Cleghorn Minerals Ltd.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Total Revenue 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 --
Selling General And Administration 165,550 109,404 172,693 105,119 --
General And Administrative Expense 165,550 109,404 172,693 105,119 --
Other Operating Expenses 11,468 30,600 16,611 16,967 --
Operating Expense 177,018 140,004 172,693 105,119 --
Operating Income -177,018 -140,004 -172,693 -105,119 --
EBIT -177,018 -140,004 -172,693 -105,119 --
Net Interest Income -- -- -- -203.00 -319.00
Pretax Income -177,018 -140,004 -172,693 -105,119 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -177,018 -140,004 -172,693 -105,119 --
Net Income From Continuing Operation Net Minority Interest -177,018 -140,004 -172,693 -105,119 --
Net Income Including Noncontrolling Interests -177,018 -140,004 -172,693 -105,119 --
Net Income Common Stockholders -177,018 -140,004 -172,693 -105,119 --
Net Income -177,018 -140,004 -172,693 -105,119 --
EBITDA -177,018 -140,004 -172,693 -105,119 --
Normalized EBITDA -177,018 -140,004 -172,693 -105,119 --
Basic EPS -0.01 -0.00 -0.01 -0.00 --
Diluted EPS -0.01 -0.00 -0.01 -0.00 --
Basic Average Shares 35.2M 31.6M 29.4M 29.4M --
Diluted Average Shares 35.2M 31.6M 29.4M 29.4M --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 --
Normalized Income -177,018 -140,004 -172,693 -105,119 --
Diluted NI Availto Com Stockholders -177,018 -140,004 -172,693 -105,119 --
Net Income Continuous Operations -177,018 -140,004 -172,693 -105,119 --
Net Non Operating Interest Income Expense -- -- -- -203.00 -319.00
Other Gand A 127,550 109,404 99,493 105,119 --
Salaries And Wages 38,000 0.00 73,200 0.00 --
Total Expenses 177,018 140,004 172,693 105,119 --
Total Other Finance Cost -- -- -- 203.00 319.00
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Cash And Cash Equivalents 170,563 137,391 26,243 122,614 --
Cash Cash Equivalents And Short Term Investments 170,563 137,391 26,243 122,614 --
Cash Financial 170,563 137,391 26,243 122,614 --
Receivables 3,363 2,920 2,645 2,591 --
Prepaid Assets 9,836 8,349 8,715 8,204 --
Current Assets 183,762 148,660 37,603 133,409 --
Net PPE -- -- -- 1.1M 1.1M
Total Non Current Assets 0.00 0.00 0.00 0.00 --
Total Assets 183,762 148,660 37,603 133,409 --
Payables And Accrued Expenses 705.00 23,966 3,687 0.00 --
Current Liabilities 705.00 23,966 3,687 0.00 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 705.00 23,966 3,687 0.00 --
Common Stock 2.8M 2.6M 2.3M 2.3M --
Capital Stock 2.8M 2.6M 2.3M 2.3M --
Additional Paid In Capital 648,601 610,601 610,601 511,018 --
Retained Earnings -3.3M -3.1M -2.9M -2.7M --
Common Stock Equity 183,057 124,694 33,916 133,409 --
Stockholders Equity 183,057 124,694 33,916 133,409 --
Total Equity Gross Minority Interest 183,057 124,694 33,916 133,409 --
Total Capitalization 183,057 124,694 33,916 133,409 --
Net Tangible Assets 183,057 124,694 33,916 133,409 --
Tangible Book Value 183,057 124,694 33,916 133,409 --
Working Capital 183,057 124,694 33,916 133,409 --
Invested Capital 183,057 124,694 33,916 133,409 --
Share Issued 38.7M 34.5M 29.4M 29.4M --
Ordinary Shares Number 38.7M 34.5M 29.4M 29.4M --
Other Equity Interest 47,238 5,238 -- 26,383 269,614
Taxes Receivable 3,363 2,920 2,645 2,591 --
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Operating Cash Flow -164,209 -119,634 -96,371 -105,683 --
Cash Flow From Continuing Operating Activities -164,209 -119,634 -96,371 -105,683 --
Stock Based Compensation 38,000 0.00 73,200 0.00 --
Change In Working Capital -25,191 20,370 3,122 -564.00 --
Change In Receivables -443.00 -275.00 -54.00 252.00 --
Change In Payables And Accrued Expense -23,261 20,279 3,687 -271.00 --
Capital Expenditure -- -- -- -- -39.00
Purchase Of PPE -- -- -- -- -39.00
Net PPE Purchase And Sale -- -- -- -- -39.00
Investing Cash Flow -- -- -- 0.00 -39.00
Cash Flow From Continuing Investing Activities -- -- -- 0.00 -39.00
Issuance Of Capital Stock 210,000 260,000 0.00 -- --
Net Common Stock Issuance 210,000 260,000 0.00 -- --
Financing Cash Flow 197,381 230,782 0.00 0.00 --
Cash Flow From Continuing Financing Activities 197,381 230,782 0.00 0.00 --
Changes In Cash 33,172 111,148 -96,371 -105,683 --
Beginning Cash Position 137,391 26,243 122,614 228,297 --
End Cash Position 170,563 137,391 26,243 122,614 --
Free Cash Flow -164,209 -119,634 -96,371 -105,683 --
Change In Prepaid Assets -1,487 366.00 -511.00 -545.00 --
Common Stock Issuance 210,000 260,000 0.00 -- --
Net Income From Continuing Operations -177,018 -140,004 -172,693 -105,119 --
Net Other Financing Charges -12,619 -29,218 -- -- -4,661
Net Other Investing Changes -- -- -- -- -39.00
Proceeds From Stock Option Exercised -- -- -- 0.00 60,000
NEWS
Loading news...
TRENDING
Loading...